Results 61 to 70 of about 3,398 (179)

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

, 2020
Importance Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23–mediated hypophosphatemia.
Econs, Michael J., Peacock, Munro, Thomsen, Lars L., Achebe, Maureen, Imel, Erik A., Wolf, Myles, Rubin, Janet, Weber, Thomas, Zoller, Heinz, Carpenter, Thomas O., Brandenburg, Vincent   +10 more
core   +1 more source

Ferric Carboxymaltose in the Treatment of Anemia in Patients with Locally Advanced Colon Cancer

Креативная хирургия и онкология
Introduction. The incidence of anemia in colorectal cancer patients reaches 30–67% depending on the stage and location of the tumor; the presence of anemia adversely affects the short-term and long-term results of radical treatment.
D. O. Kornev, A. N. Moskalenko, E. S. Kuzmina, V. K. Lyadov   +3 more
doaj   +1 more source

The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review

Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 44-59, January 2026.
Abstract Background Pregnancy after a Parkinson's diagnosis presents complex challenges. Due to the paucity of literature, there is no evidence‐based guidelines and protocols for preconception care, management of pregnancy, childbirth and the postpartum period in women with early‐onset Parkinson's disease (PD).
Alexander C. Lehn, Jee‐Young Lee, Giorgia Sciacca, Stacy Patterson, Adam Morton, Paul Pun, Walaa A. Kamel, Marina Picillo, Bart Post, Eng‐King Tan, Tamine Capato, Bastiaan R. Bloem, Manon Auffret, Annelien M. Oosterbaan, Willanka Kapelle, Michiko K. Bruno, Lorraine V. Kalia, Jeffrey H. Kordower, Daniela Berg   +18 more
wiley   +1 more source

Hypophosphatemia after intravenous iron repletion with ferric carboxymaltose and iron isomaltoside : the randomized controlled HOMe aFers study

, 2021
Inzidenz der Hypophosphatämie nach intravenöser Eisensubstitution mittels Eisen Carboxymaltose und Eisen Derisomaltose – Ergebnisse der randomisierten, kontrollierten HOMe aFers Studie Hintergrund: Bei Patienten mit Eisenmangelanämie ermöglichen Eisen ...
Siegel, Jonathan David
core   +1 more source

Treatment of iron deficiency anemia in the preoperative preparation of patients with uterine myoma

Медицинский совет, 2015
Iron deficiency anemia (IDA) is one of the most common conditions in patients with uterine myoma. The purpose of the study was to evaluate efficacy and safety of intravenous administration of ferric carboxymaltose in patients with iron deficiency anemia ...
T. A. Fedorova, O. V. Rogachevskiy, E. V. Strelnikova, T. Y. Ivanets, T. V. Bulynina   +4 more
doaj   +1 more source

Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside

, 2019
Background: Iron deficiency and iron deficiency anaemia are common complications in inflammatory bowel disease (IBD). In patients with moderate‐to‐severe anaemia, oral iron intolerance or ineffectiveness of oral iron, ferric carboxymaltose and iron ...
Zoller, Heinz, Moum, Bjørn, Jahnsen, Marte Eide, Finnes, Elisabeth, Detlie, Trond Espen, Lindstrøm, Jonas Christoffer, Jahnsen, Jørgen   +6 more
core   +1 more source

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose

JGH Open, 2019
Intravenous iron is commonly prescribed for treatment of iron deficiency, with modern formulations demonstrating an acceptable safety profile in the majority of patients.
Wendy Fang, Lawrence P McMahon, Stephen Bloom, Mayur Garg   +3 more
doaj   +1 more source

Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo

Frontiers in Immunology, 2019
Background: Intravenous (IV) iron is widely used to treat anemia in chronic kidney disease patients. Previously, iron formulations were shown to induce immune activation in-vitro. The current study aimed to investigate the effect of IV iron on complement
Bernardo Faria, Bernardo Faria, Bernardo Faria, Mariana Gaya da Costa, Felix Poppelaars, Casper F. M. Franssen, Manuel Pestana, Stefan P. Berger, Mohamed R. Daha, Mohamed R. Daha, Carlo A. J. M. Gaillard, Marc A. Seelen   +11 more
doaj   +1 more source

Intravenous iron-induced hypophosphatemia and kidney stone disease

Bone Reports
Patients with Crohn's disease are at increased risk for symptomatic nephrolithiasis. Stones in these patients are most commonly composed of calcium oxalate monohydrate or mixed calcium-oxalate and calcium-phosphate. Precipitation of both minerals depends
Marlene Panzer, Eva Meindl, Benedikt Schaefer, Sonja Wagner, Bernhard Glodny, Gert Mayer, Andreas Pircher, Christoph Schwarz, Felix Beckmann, Clivia Hejny, Bastian Joachim-Mrosko, Juergen Konzett, Herbert Tilg, Isabel Heidegger, Myles Wolf, Ralf Weiskirchen, Heinz Zoller   +16 more
doaj   +1 more source

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study

BMC Medicine, 2020
Background In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosphatemia after an equivalent dosage ...
I. E. Emrich, F. Lizzi, J. D. Siegel, S. Seiler-Mussler, C. Ukena, D. Kaddu-Mulindwa, R. D’Amelio, S. Wagenpfeil, V. M. Brandenburg, M. Böhm, D. Fliser, G. H. Heine   +11 more
doaj   +1 more source